A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms	neoplasm	Recruiting	Phase 1	2026-09-25		NCT06150157

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Janssen Research & Development, LLC	188

44 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Arthur J E Child Comprehensive Cancer Centre	Calgary	Canada	2
Carmel Medical Center	Haifa	Israel	24
CH LYON SUD - Hematology	Pierre-Bénite	France	1
Charite Campus Benjamin Franklin	Berlin	Germany	6
Churchill Hospital	Oxford	United Kingdom	43
City of Hope	Duarte	United States	238
Emory University	Atlanta	United States	262
Guy's and St Thomas' Hospital	London	United Kingdom	1
Hadassah University Hospita Ein Kerem	Jerusalem	Israel	7
Hopital Saint Louis	Paris	France	10
Hosp. Clinico Univ. de Valencia	Valencia	Spain	21
Hosp. Univ. Germans Trias I Pujol	Badalona	Spain	28
Institut Universitaire du Cancer Toulouse Oncopole	Toulouse	France	13
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences	Tianjin	China	1
Jewish General Hospital	Montreal	Canada	130
Juntendo University Hospital	Bunkyō City	Japan	9
Levine Cancer Institute	Charlotte	United States	110
MD Anderson Cancer Center	Houston	United States	589
Med. Universitatsklinik Essen	Essen	Germany	2
Medizinische Hochschule Hannover	Hanover	Germany	90
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Moffit Cancer Center	Tampa	United States	20
Montefiore Medical Center	The Bronx	United States	198
National Cancer Center Hospital East	Kashiwa	Japan	14
Peking Union Medical College Hospital	Beijing	China	7

Clinical trials